ArticleInternational journal of general medicine2023
A Revised PADMA Scoring System for Predicting in-Hospital Mortality in Acute Coronary Syndrome Patient.
Article in International journal of general medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- In-hospital mortality risk prediction models for patients with acute coronary syndrome: a systematic review and meta-analysis.Frontiers in cardiovascular medicine · 2025Pooled it
- Anemia, Hyperglycemia, and Reduced Left Ventricular Ejection Fraction Improve the GRACE Score's Predictability for In-hospital Mortality in Acute Coronary Syndrome; Single-Centre Cross-Sectional Study.Open access emergency medicine : OAEM · 2025Article
- Article
- Advancements in Myocardial Infarction Management: Exploring Novel Approaches and Strategies.Cureus · 2023Review
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In order to predict in-hospital mortality in ACS (Acute Coronary Syndrome) patients based solely on clinical examination, this study compares the shock index (heart rate divided by systolic blood pressure) variable in PADMA (PADjadjaran Mortality in Acute Coronary Syndrome) with the modified shock index (heart rate divided by mean arterial pressure) score. The predictive efficacy of the PADMA score in predicting in-hospital mortality in ACS patients has been in doubt up until recently. Methods: All ACS patients above the age of 18 who were admitted to Dr. Hasan Sadikin Central General Hospital between January 2018 and January 2023 were included in this retrospective observational cohort study. This study did not involve any interventions, and verbal informed permission was obtained with the Hasan Sadikin Hospital Ethic Committee's approval. Multivariate logistic regression was used to gather and evaluate patient demographic, comorbidity, and clinical presentation data in order to provide two scoring systems (probability and cut-off models) that can be used to predict in-hospital all-cause death. The Fisher Z test was used to assess the area under the curve (AUC) between the PADMA SI (shock index) and PADMA MSI (modified shock index). Results: Killip classifications III and IV, tachycardia, a high shock index, and older age were found to be independent mortality predictors and were included to the PADMA MSI score by multivariate regression analysis of 1504 people. PADMA SI score >8 has a sensitivity of 67.92% and a specificity of 84.01% for predicting all-cause death. The range of the PADMA SI score is 0 to 19. The AUC between the PADMA MSI and PADMA SI scores did not differ significantly (p=0.022). Conclusion: Similar to the PADMA SI score, the PADMA MSI score >8 demonstrated an accurate discriminative power to forecast in-hospital mortality though it did not have significant statistic difference.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.